Encompass Health Corp (NYSE: EHC) on Tuesday, soared 0.61% from the previous trading day, before settling in for the closing price of $116.31. Within the past 52 weeks, EHC’s price has moved between $82.74 and $117.98.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 3.59%. The company achieved an average annual earnings per share of 13.30%. With a float of $99.17 million, this company’s outstanding shares have now reached $100.90 million.
Considering the fact that the conglomerate employs 40000 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 36.45%, operating margin of 16.76%, and the pretax margin is 14.69%.
Encompass Health Corp (EHC) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Care Facilities industry stocks is more important than anything else. The insider ownership of Encompass Health Corp is 1.61%, while institutional ownership is 95.67%. The most recent insider transaction that took place on Apr 29 ’25, was worth 1,147,900. In this transaction EVP, Gen Counsel & Secretary of this company sold 10,000 shares at a rate of $114.79, taking the stock ownership to the 79,710 shares. Before that another transaction happened on Apr 29 ’25, when Company’s EVP & Chief Financial Officer sold 43,575 for $115.15, making the entire transaction worth $5,017,538. This insider now owns 60,335 shares in total.
Encompass Health Corp (EHC) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 13.30% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 11.40% during the next five years compared to 4.32% growth over the previous five years of trading.
Encompass Health Corp (NYSE: EHC) Trading Performance Indicators
Encompass Health Corp (EHC) is currently performing well based on its current performance indicators. A quick ratio of 1.06 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.14. Likewise, its price to free cash flow for the trailing twelve months is 30.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 4.84, a number that is poised to hit 1.21 in the next quarter and is forecasted to reach 5.59 in one year’s time.
Technical Analysis of Encompass Health Corp (EHC)
Compared to the last year’s volume of 0.81 million, its volume of 0.86 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 93.54%. Additionally, its Average True Range was 3.33.
During the past 100 days, Encompass Health Corp’s (EHC) raw stochastic average was set at 96.81%, which indicates a significant increase from 95.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.97% in the past 14 days, which was higher than the 30.97% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $102.30, while its 200-day Moving Average is $97.11. Nevertheless, the first resistance level for the watch stands at $117.90 in the near term. At $118.78, the stock is likely to face the second major resistance level. The third major resistance level sits at $120.15. If the price goes on to break the first support level at $115.65, it is likely to go to the next support level at $114.28. Now, if the price goes above the second support level, the third support stands at $113.40.
Encompass Health Corp (NYSE: EHC) Key Stats
Market capitalization of the company is 11.80 billion based on 100,797K outstanding shares. Right now, sales total 5,373 M and income totals 455,700 K. The company made 1,455 M in profit during its latest quarter, and 151,500 K in sales during its previous quarter.